These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 7527342

  • 1. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.
    Reimer A, Paul T, Kallfelz HC.
    Am J Cardiol; 1991 Sep 15; 68(8):741-4. PubMed ID: 1892080
    [Abstract] [Full Text] [Related]

  • 3. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T, Lehmann C, Pfammatter JP, Kallfelz HC.
    Z Kardiol; 1994 Dec 15; 83(12):891-7. PubMed ID: 7531374
    [Abstract] [Full Text] [Related]

  • 4. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P, Drago F, Di Donato RM, Cicini MP, Pasquini L, Marino B, Marcelletti C, Ragonese P.
    Am Heart J; 1991 Oct 15; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.
    Am J Cardiol; 2017 May 01; 119(9):1366-1370. PubMed ID: 28283175
    [Abstract] [Full Text] [Related]

  • 6. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 7. Supraventricular tachycardia in children.
    Van der Merwe DM, Van der Merwe PL.
    Cardiovasc J S Afr; 2004 Nov 14; 15(2):64-9. PubMed ID: 15148540
    [Abstract] [Full Text] [Related]

  • 8. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F, Jabón A.
    An Esp Pediatr; 1993 Dec 14; 39(6):475-88. PubMed ID: 8166400
    [No Abstract] [Full Text] [Related]

  • 9. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J, Paul T.
    Am J Cardiol; 1998 May 01; 81(9):1121-4. PubMed ID: 9605053
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Nov 01; 31(11):1347-59. PubMed ID: 9391691
    [Abstract] [Full Text] [Related]

  • 11. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
    Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R.
    Anesth Analg; 2008 Nov 01; 107(5):1514-22. PubMed ID: 18931208
    [Abstract] [Full Text] [Related]

  • 12. [High frequency current ablation of supraventricular tachyarrhythmias in congenital heart defects].
    Hebe J, Antz M, Siebels J, Volkmer M, Ouyang F, Kuck KH.
    Herz; 1998 Jun 01; 23(4):231-50. PubMed ID: 9690111
    [Abstract] [Full Text] [Related]

  • 13. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG, Camm AJ.
    Drugs; 1995 Aug 01; 50(2):250-62. PubMed ID: 8521758
    [Abstract] [Full Text] [Related]

  • 14. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 01; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 15. [Supraventricular tachycardia in infants, children and adolescents: diagnosis, drug and interventional therapy].
    Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G.
    Z Kardiol; 2000 Jun 01; 89(6):546-58. PubMed ID: 10929440
    [Abstract] [Full Text] [Related]

  • 16. [Use of propafenone in emergency therapy].
    Liguori A, Pellegrino G, Di Ieso N, Piatto A, Ruggiero P, Scarnera P, Guardascione A.
    Clin Ter; 1989 Dec 15; 131(5):307-14. PubMed ID: 2532584
    [Abstract] [Full Text] [Related]

  • 17. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q, Wang Z, Peng D.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Dec 15; 22(2):123-6. PubMed ID: 9868052
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia.
    Pintarić H, Zeljković I, Babić Z, Vrsalović M, Pavlović N, Bosnjak H, Petrac D.
    Croat Med J; 2012 Dec 15; 53(6):605-11. PubMed ID: 23275326
    [Abstract] [Full Text] [Related]

  • 20. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.